广域接入设备市场-按产品,应用,最终用途-全球预测,2025年至2034年

Wide Area Access Equipment Market Size

The global vascular access device market size was valued at USD 5.8 billion in 2024 and is expected to grow at a CAGR of 7.1% during 2025-2034. The increasing prevalence of chronic diseases, including cancer, renal failure, and cardiovascular disease, around the world has led to a need for vascular access devices. The World Health Organization (WHO) states that there will be an estimated 20 million new cancer cases and 9.7 million deaths in 2022. They require prolonged intravenous treatments for oncology such as chemotherapy, dialysis, and antibiotics, which require reliable vascular access.

This demand is also supported by the aging population, which often requires more frequent treatments due to these health conditions. The United Nations states that by 2050, one-sixth of the world’s population will be over 65 years old, reflecting the continued need for vascular access devices in the management of chronic diseases.

In addition, the increase in elective and emergency surgeries and hospitalizations around the world has led to a continued demand for vascular access devices. The World Health Organization estimates that approximately 234 million major surgeries are performed worldwide each year. Fluid management, anesthesia, and postoperative care all rely on vascular access devices. The expansion of healthcare infrastructure, especially in emerging markets, supports the continued increase in vascular access devices for hospitalized patients.

Vascular access devices are devices that facilitate direct patient access to the vascular system to administer or remove fluids, blood products, medications, or nutrients. These devices play an important role in the clinical setting and can support a variety of procedures, from short procedures such as fluid replacement during surgery and anesthesia to longer treatments such as chemotherapy, dialysis, and intravenous nutrition.

Wide Area Access Equipment Market Trends

• Practitioners are adopting minimally invasive, image-guided techniques for vascular access placement, particularly under ultrasound guidance. This approach can reduce insertion-related complications, improve patient comfort, and increase procedural success rates. This trend has increased demand for vascular access devices with enhanced visualization and safety.
• Apart from this, companies are designing vascular access devices with antimicrobial coatings and anti-thrombotic materials to prevent catheter-related bloodstream infections and thrombi. For example, Becton Dickinson and Company offers the PowerGlide Pro Midline Catheter and BioFlo PICC with Endexo and BD Vascular Access Shield Technology, which use blood pressure and anti-infection materials. Also, Teleflex manufactures the ARROWg+ard blue catheter, which contains a chlorhexidine coating that has been shown to reduce bacterial adhesion.
• These catheters are utilized in all oncology care settings and critical care settings, with long-term availability and infection control being the primary considerations in purchasing decisions.
• Furthermore, home therapy procedures are driving the market owing to the growing emphasis on value-based care. PICCs and implantable ports are some of the devices that allow patients to receive intravenous therapies in an outpatient or home setting, thereby reducing hospital stays. This trend is particularly evident in the treatment of chronic diseases such as cancer and infections.
• 广域接入装置越来越多地纳入数字传感器和连接,以实时监测流量、压力和装置状况。 这些技术改进了对隔离或装置故障的及时检测,并减少了并发症。 这一趋势是数字保健和远程病人管理更趋一致的一部分。

广域访问设备市场分析

基于产品,市场分为外围血管接入装置和中央血管接入装置. 中央血管接入装置部分占市场主导地位,2024年收入份额最大,为63.9%。

• 中央血管接入装置在反复或连续输液的管理中,特别是在癌症治疗中,发挥着非常重要的作用.
• 全世界癌症患者和化疗作为一种常见治疗形式的增长,正在产生对隧道导管、可移植港口和石化控制中心的大量需求。 这些导致插入频率减少,患者长期治疗不适。
• 抗微生物涂层,抗流体材料,闭系统连接器等产品创新改进了CVAD安全配置. 这些创新将感染、与导管有关的血液感染(CRBSIs)和凝血等并发症减少到最低程度,从而导致保健提供者更高度的采用。
• 此外,较新的插入技术,如图像制导的放置,提高了不同保健设施使用CVAD的效率和安全性,推动了这些技术的采用。

根据应用情况,血管接入器械市场分为药物管理、液体和营养管理、输血、诊断检测和其他应用。 2024年,毒品管理部门占市场主导地位,收入最高,为24亿美元。

• 癌症、传染病、自体免疫疾病和心血管疾病等慢性疾病的发病率上升,正在推动在长期药物治疗中使用血管接入装置。 慢性病占全世界死亡总人数的32%,根据心脏研究所,心血管疾病每年造成1 790万人死亡。
• 在治疗抗生素、化疗药物、免疫疗法和生物学期间,经常进行持续的或慢性的药物注射。 因此,由于疾病负担加重,需要可靠的血管接入解决方案,以帮助长期提供药物。
• 此外,世界范围的保健系统正在推动转向家庭护理和门诊护理,而不是住院护理,以降低费用,提高病人的舒适度。 这一变化正在推动医院外药物管理部门使用血管接入装置,特别是在那些需要长期抗生素疗法、疼痛管理或亲子营养的病人中,这有助于该部分的收入增长。

根据最终使用情况,血管接入设备市场分为医院和诊所、流动外科中心、家庭护理设施和其他最终用户。 2024年,医院和诊所部分占市场支配地位,占56.2%。

• 世界各地专科诊所和医院的选修手术和高级手术程序增加,造成对血管接入产品的持续需求。 它们被用于手术内麻醉、流体管理和术后药物管理。 医院和诊所等医疗设施需要短期产品,如周边IV和中线,以及长期恢复期较长的产品。
• 医院和诊所面临越来越多的临床和监管压力,以减少与导管有关的血液感染和其他并发症。 这鼓励更多地采用带有封闭系统和防护装置的尖端抗微生物带血管接入装置。
• 此外,医院等急性保健环境对减少与保健有关的感染和保护病人的需求正在使市场需求转向使用更安全和先进的带抗微生物涂层的血管接入产品,这进一步帮助了该部分的收入增长。

2024年,北美血管接入装置市场价值为26亿美元,预计在预测期间CAGR将增长7%。 该区域慢性病、癌症和心血管疾病的发病率不断上升,推动了市场的发展。

美国市场预计将从2024年的23亿美元大幅增长到2034年的46亿美元.

• 在美国,糖尿病,癌症,心血管疾病,肾衰竭等慢性病的流行范围不断扩大,助长了长期静脉注射治疗的需求. 10个美国成年人中有6个至少患有1个慢性病,10个成年人中有4个有2个或2个以上,报告疾病控制和预防中心. 广度接入装置是提供化疗、透析、亲和营养以及长期抗生素疗法的支柱。
• 这些慢性病与老龄化人口的融合,加上美国人口调查局估计2034年有7700万65岁及以上人口,使得医院和家庭护理场所对中央及外围接驳设备的需求继续升级. 这种人口变化反映了在慢性病管理中使用血管接入器械的持续增长格局.
• 美国的医疗保健系统正在转向家庭和门诊护理,同时增加了住院费用和病人对家庭治疗的偏好。 广度接入装置,特别是PICC和可植入的港口,允许在医院外安全长期使用药物。
• 全国流动输注中心和家庭输注服务的增长正在推动市场的巨大增长。

欧洲血管接入装置市场在2024年的价值为15亿美元,预计在预测期间CAGR将增长6.8%。

• 欧洲的人口正在迅速老龄化,特别是在意大利和德国等国家,与此同时,肾脏疾病、癌症和心血管疾病等长期疾病的发病率也在上升。
• 这些疾病通常是长期性疾病,需要长时间的静脉注射疗法、透析或长期住院治疗,因此长期需要血管接入装置,以便利治疗。
• 此外,在欧洲大多数国家,公共资助的方案具有普遍覆盖面,因此有可能采用先进的医疗技术,如血管接入装置。
• 国家保健政策鼓励报销方案和循证、降低费用设备的使用,以促进住院和门诊的利用。 因此,预计上述因素将大大促进预测期间的区域增长。

2025年至2034年,联合王国的血管接入装置市场预计将有显著和有希望的增长。

• 英国癌症发病率不断上升,导致化疗中需要中央血管接入装置,如可植入端口和隧道导管. 根据英国癌症研究,到2040年,联合王国每年将有50多万人被诊断患有癌症。 癌症治疗的NHS途径取决于药物治疗的长期血管接触。
• 肿瘤服务和癌症筛查方案的扩大表明血管接入装置的使用长期增长。 国家保健服务癌症方案对早期诊断和更容易获得治疗的承诺表明,血管接入装置对提供癌症护理的需求长期增长。
• 英国国家卫生局(NHS)面临越来越大的压力,要求减少保健和住院床位费用。 这鼓励了更多使用血管接触装置,如PIC和中线,从而能够进行早期和家用治疗。
• 这些装置允许在医院外进行静脉注射治疗,增加了NHS中心利用率和病人流量,这进一步便利了这些药物在国内的采用。

亚太血管接入装置市场预计将在预测期间以最快的CAGR增长7.7%。

• 印度、中国、印度尼西亚和越南正在显著提升对私营和公共保健设施的投资。 它涉及发展新医院,增加关键护理服务,提高外科和诊断能力,这些要素正在推动城市和农村保健中心更多地使用血管接入装置。
• 亚太还目睹了诸如糖尿病、癌症和肾衰竭等非传染性疾病的流行,这些疾病是由于城市化、人口老龄化和生活方式造成的。
• 他们通过长期治疗、透析和反复抽血得到治疗,所有这些都意味着对血管接入装置的大量需要,如中央毒气导管、PICC和港口。

日本血管接入器械市场预计将在2025-2034年间出现有利可图的增长。

• 日本是世界上最古老的人口之一。 例如,世界经济论坛指出,全国每10人中就有1人以上年龄在80岁或以上,三分之一的人口年龄在65岁或以上。
• 随着医院、疗养院和家庭护理环境使用量的扩大,这一趋势表明,日本保健设施使用血管接入装置的情况稳步增加。
• 日本是全世界人均透析病人比例最高的国家,主要是老年人和糖尿病患者。 中央血管接入装置,如隧道导管,在动脉瘘管不可行的情况下使用. 日本各地医院和门诊透析设施对透析疗法的持续需求推动了血管接入装置的使用。

巴西血管接入装置市场预计将在2025-2034年期间出现有利可图的增长。

• 巴西公共保健系统是国家政府的一个联系组织,为75%以上的公民提供免费保健服务。 由于政府在更新医院和改善获得新疗法方面的投资,对血管接入装置等医疗设备的需求正在增加。
• 根据经济合作与发展组织(经合组织),癌症是巴西第三大死亡原因之一。 此外,巴西还看到糖尿病和末期肾病等慢性病迅速增长。
• 这些疾病主要通过化疗、透析和亲乳营养来治疗,它们都依赖于血管接入装置,如中央线路、港口和PICC。 这种流行病学转变是稳定市场需求的主要动力。

Middle East and Africa: Saudi Arabia vascular access devices market is expected to witness significant and promising growth during the period 2025 to 2034.

• Saudi Arabia has a growing healthcare demand due to a wide range of lifestyle-related diseases such as diabetes, cardiovascular disease, and cancer. The International Diabetes Federation (IDF) reports that Saudi Arabia has one of the highest rates of diabetes in the world, with approximately 17.7% of the adult population suffering from diabetes in 2021. These chronic diseases require extensive intravenous therapies, including insulin infusions, chemotherapy, and antibiotic therapy, which necessitates the use of vascular access devices.
• Increased government emphasis on managing noncommunicable diseases through timely diagnosis and increased treatment options has further sustained the demand for vascular access devices in healthcare facilities, especially in the management of these common diseases.
• Part of the Saudi Vision 2030 initiative involves significant investment in health infrastructure, aimed at increasing the capacity of the country's hospitals, strengthening clinical services and increasing access to health technologies. This includes installing higher quality vascular access devices with increased safety features to meet international health standards. Continuous improvements in hospitals and specialist clinics through public-private partnerships have fueled the use of vascular access products across the country.

Wide Area Access Equipment Market Share

The market is dynamic and comprises of both international and domestic players offering innovative solutions to meet the growing demand for advanced devices from the growing patient population. Companies such as Becton Dickinson and Company, Teleflex, B.Braun, Medtronic, and Fresenius Medical are some of the dominant players in the market, collectively accounting for approximately 60% of the market share.

Competition in this field stems from continuous technological development and the ability to provide customized solutions. In developing countries, multinational companies are squeezed to provide vascular access devices that are both affordable and high-quality due to the priority given to cost. Domestic manufacturers take advantage of this demand and provide cost-effective alternatives, allowing multinational companies to change their pricing strategies while maintaining the safety, ruggedness and regulatory acceptability of their products.

Wide Area Access Equipment Market Companies

Some of the prominent market players operating in the vascular access devices industry include:

• Access Width
• Animation
• Braun
• becton dickinson
• Kangvatek
• Chef Medical
• Fresenius Medical Care
• ICU Medical
• Medical section
• Medtronics
• Nipro
• Pen
• telegraph
• Trumo
• Vigon
• Becton Dickinson and Company has market dominance in vascular access devices through its safety-engineered catheters, such as the BD Nexiva Occlusive IV Catheter System. The system minimizes needlestick injuries and bloodstream infections through an integrated closure design. The company’s PICC and midline catheters feature PowerGlide technology for superior insertion.
• Teleflex pioneered the market with its Arrow product line, an ultrasound-compatible peripherally inserted central catheter (PICCs) and central ventilator catheters (CVCs) that ensure more accurate placement. The Arrow VPS Rhythm System uses ECG tip confirmation technology to reduce placement errors.
• B. Braun specializes in dialysis solutions and critical care under its Introcan Security and Certofix brands, with a focus on material compatibility and precision engineering. Its Vasofix Security IV catheter brand includes passive safety devices that reduce the risk of needlestick injuries, and Ecoflon coatings that reduce thrombotic complications in long-term use applications.

Wide Area Access Equipment Industry News:

• In January 2025, Penumbra launched the Elements Vascular Access System, a laser-cut prosthetic tube kit for the treatment of toxic thrombi (VTE). Elements is designed to be used in conjunction with the Lightning Bolt 2.0 Mechanical Resection System to efficiently remove toxic blood and treat pulmonary embolism. The launch further establishes Penumbra's leadership in the vascular intervention segment by adding a more integrated device to its portfolio.
• In October 2024, Becton, Dickinson and Company (BD), a global leader in medical technology, launched the BD Intraosseous Vascular Access System to enable rapid access to fluids or medications in life-threatening emergencies. The introduction complements BD's emergency care portfolio and its commitment to improving outcomes in high-acute clinical settings.
• In September 2024, Access Vascular, a key company in vascular access innovation through its aquatic biomaterial technology, announced a strategic partnership with Capstone Health Alliance, a regional group purchasing organization. The transaction enables the availability of MIMIX aquatic catheters to more facilities through Capstone's more than 300 U.S. hospitals, independent health systems and physician practices.
• In November 2023, Becton, Dickinson and Company (BD), a global medical technology pioneer, introduced an ultrasound system that enables clinicians to quickly and easily map the vascular space to improve the placement of vascular access devices such as peripherally inserted central catheters (PICCs), stroke catheters, IV lines, etc. The release boosts BD's vascular access business and advances its vision to bring procedural excellence and improved patient outcomes into daily clinical practice.

Vascular Access Devices Market research report includes in-depth coverage of the industry with estimated and forecasted revenues of USD million during 2021-2034 for the following segments:

By product

• Peripheral vascular access devices
• Central Vascular Access Device

Via the application

• Medication management
• Fluid and Nutrition Management
• Blood transfusion
• Diagnostic testing
• Other applications

Final use

• Hospitals and clinics
• Outpatient Surgery Center
• Home care environment
• Other end uses

The above information is provided for the following regions and countries:

• North America
  • USA.
  • Canada
• Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Page:1
  • Netherlands
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • United Nations
  • Mexico
  • USA
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • United Arab Emirates